Southeast Asset Advisors LLC Takes $1.42 Million Position in Amrize Ltd $AMRZ

Southeast Asset Advisors LLC purchased a new position in shares of Amrize Ltd (NYSE:AMRZFree Report) during the third quarter, Holdings Channel reports. The firm purchased 29,200 shares of the company’s stock, valued at approximately $1,417,000.

A number of other hedge funds have also recently added to or reduced their stakes in AMRZ. Vanguard Group Inc. raised its holdings in Amrize by 41.0% in the 3rd quarter. Vanguard Group Inc. now owns 30,094,083 shares of the company’s stock valued at $1,468,460,000 after acquiring an additional 8,743,543 shares in the last quarter. PNC Financial Services Group Inc. bought a new stake in Amrize during the third quarter worth about $1,360,000. Kailix Advisors LLC grew its stake in Amrize by 50.4% during the third quarter. Kailix Advisors LLC now owns 205,450 shares of the company’s stock worth $9,970,000 after buying an additional 68,870 shares in the last quarter. Public Sector Pension Investment Board increased its holdings in Amrize by 8.8% in the 3rd quarter. Public Sector Pension Investment Board now owns 306,957 shares of the company’s stock valued at $14,811,000 after buying an additional 24,738 shares during the period. Finally, Cibc World Market Inc. bought a new stake in shares of Amrize during the 3rd quarter worth approximately $423,000.

Wall Street Analyst Weigh In

Several brokerages have commented on AMRZ. Citigroup boosted their price objective on shares of Amrize from $63.00 to $67.00 and gave the company a “buy” rating in a research report on Thursday, January 8th. Royal Bank Of Canada lowered Amrize from an “outperform” rating to a “sector perform” rating and raised their price objective for the company from $56.00 to $60.00 in a research note on Monday, December 8th. Kepler Capital Markets raised shares of Amrize to a “strong-buy” rating in a report on Tuesday, October 21st. Vertical Research started coverage on shares of Amrize in a research note on Tuesday, November 25th. They issued a “hold” rating and a $54.00 price target on the stock. Finally, Morgan Stanley set a $61.00 price objective on shares of Amrize and gave the stock an “overweight” rating in a research report on Wednesday, October 29th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $60.75.

Check Out Our Latest Stock Analysis on AMRZ

Amrize Price Performance

Shares of NYSE:AMRZ opened at $58.86 on Monday. The firm has a market cap of $32.55 billion and a PE ratio of 31.99. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.97 and a current ratio of 1.45. Amrize Ltd has a 52 week low of $44.12 and a 52 week high of $60.57. The firm’s fifty day moving average is $55.38 and its 200-day moving average is $52.12.

Insider Activity at Amrize

In related news, Director Nicholas C. Gangestad acquired 2,000 shares of the stock in a transaction dated Wednesday, November 19th. The stock was bought at an average cost of $47.34 per share, for a total transaction of $94,680.00. Following the completion of the transaction, the director directly owned 4,958 shares of the company’s stock, valued at $234,711.72. The trade was a 67.61% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

About Amrize

(Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Featured Articles

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZFree Report).

Institutional Ownership by Quarter for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.